Trial · NCT02493725
JET-GBS - Japanese Eculizumab Trial for GBS
NCT02493725, Phase 2, Completed, Chiba University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. JET-GBS - Japanese Eculizumab Trial for GBS. Trials, record NCT02493725. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02493725
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- JET-GBS - Japanese Eculizumab Trial for GBS
- NCT number
- NCT02493725
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 34 participants, actual
- Lead sponsor
- Chiba University
- Conditions
- Gullain Barre Syndrome
- Interventions
- Eculizumab, Placebo
- First posted
- 2015-07-09
- Last updated
- 2017-10-11
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | [Safety] Expressed frequency and severity of incidence of AE/SAEs after treatment with investigational product. | 6 months | |
| Primary | [Efficacy] Proportion of subjects who reach a score of FG2 or lower on the Hughes functional grading scale at week 4（Response Rate） | 4 weeks | |
| Secondary | Proportion of subjects with improvement of one or more scores on the functional grading scale at each visit | 6 months | |
| Secondary | Proportion of subjects who are able to walk unaided (FG2 or lower) at each visit | 6 months | |
| Secondary | Duration required for improvement by at least one grade on the Hughes functional grading scale | 6 months | |
| Secondary | Proportion of subjects who reach FG1 or 0 at week 24 | 6 months | |
| Secondary | Change in the FG score between peak disability score and the scores at each visit | 6 months | |
| Secondary | Proportion of subjects with a clinically relevant improvement in the R-ODS score. An increase in the R-ODS score (0-48) converted to the centile metric score (0-100) by at least six points at each visit | 6 months | |
| Secondary | Proportion of subjects with a clinically relevant improvement in ONLS. (a decrease in the ONLS score from baseline by at least 1 point) at each visit | 6months | |
| Secondary | Proportion and frequency of subjects who require ventilatory support (F 5) | 4 weeks |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02493725
GET https://conductscience.org/api/trials/v1/NCT02493725/registered?page=2